177 related articles for article (PubMed ID: 9086401)
1. Development of sterically stabilized poly(isobutyl 2-cyanoacrylate) nanoparticles by chemical coupling of poly(ethylene glycol).
Peracchia MT; Vauthier C; Puisieux F; Couvreur P
J Biomed Mater Res; 1997 Mar; 34(3):317-26. PubMed ID: 9086401
[TBL] [Abstract][Full Text] [Related]
2. Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles.
Peracchia MT; Vauthier C; Passirani C; Couvreur P; Labarre D
Life Sci; 1997; 61(7):749-61. PubMed ID: 9252249
[TBL] [Abstract][Full Text] [Related]
3. The effect of poly(ethylene glycol) coating and monomer type on poly(alkyl cyanoacrylate) nanoparticle interactions with lipid monolayers and cells.
Baghirov H; Melikishvili S; Mørch Y; Sulheim E; Åslund AKO; Hianik T; de Lange Davies C
Colloids Surf B Biointerfaces; 2017 Feb; 150():373-383. PubMed ID: 27842930
[TBL] [Abstract][Full Text] [Related]
4. Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity.
Shi B; Fang C; Pei Y
J Pharm Sci; 2006 Sep; 95(9):1873-87. PubMed ID: 16795003
[TBL] [Abstract][Full Text] [Related]
5. Preparation of poly(MePEGCA-co-HDCA) nanoparticles with confined impinging jets reactor: experimental and modeling study.
Lince F; Bolognesi S; Marchisio DL; Stella B; Dosio F; Barresi AA; Cattel L
J Pharm Sci; 2011 Jun; 100(6):2391-405. PubMed ID: 21259236
[TBL] [Abstract][Full Text] [Related]
6. Novel polysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticles.
Chauvierre C; Labarre D; Couvreur P; Vauthier C
Pharm Res; 2003 Nov; 20(11):1786-93. PubMed ID: 14661923
[TBL] [Abstract][Full Text] [Related]
7. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
Sant S; Poulin S; Hildgen P
J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of polyalkylcyanoacrylate nanoparticles as a potential drug carrier: preparation, morphological characterization and loading capacity.
Puglisi G; Giammona G; Fresta M; Carlisi B; Micali N; Villari A
J Microencapsul; 1993; 10(3):353-66. PubMed ID: 8377093
[TBL] [Abstract][Full Text] [Related]
9. Effect of aqueous solubility of grafted moiety on the physicochemical properties of poly(d,l-lactide) (PLA) based nanoparticles.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2010 Mar; 388(1-2):263-73. PubMed ID: 20060450
[TBL] [Abstract][Full Text] [Related]
10. Preparation of biodegradable nanoparticles of tri-block PLA-PEG-PLA copolymer and determination of factors controlling the particle size using artificial neural network.
Asadi H; Rostamizadeh K; Salari D; Hamidi M
J Microencapsul; 2011; 28(5):406-16. PubMed ID: 21736525
[TBL] [Abstract][Full Text] [Related]
11. Room-temperature preparation and characterization of poly (ethylene glycol)-coated silica nanoparticles for biomedical applications.
Xu H; Yan F; Monson EE; Kopelman R
J Biomed Mater Res A; 2003 Sep; 66(4):870-9. PubMed ID: 12926040
[TBL] [Abstract][Full Text] [Related]
12. Poly(ester urethane)s consisting of poly[(R)-3-hydroxybutyrate] and poly(ethylene glycol) as candidate biomaterials: characterization and mechanical property study.
Li X; Loh XJ; Wang K; He C; Li J
Biomacromolecules; 2005; 6(5):2740-7. PubMed ID: 16153114
[TBL] [Abstract][Full Text] [Related]
13. Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer.
Peracchia MT; Vauthier C; Desmaële D; Gulik A; Dedieu JC; Demoy M; d'Angelo J; Couvreur P
Pharm Res; 1998 Apr; 15(4):550-6. PubMed ID: 9587950
[TBL] [Abstract][Full Text] [Related]
14. Soluble telmisartan bearing poly (ethylene glycol) conjugated chitosan nanoparticles augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in human cervical cancer cells.
Sharma A; Jyoti K; Bansal V; Jain UK; Bhushan B; Madan J
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():69-76. PubMed ID: 28024639
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles bearing polyethyleneglycol-coupled transferrin as gene carriers: preparation and in vitro evaluation.
Li Y; Ogris M; Wagner E; Pelisek J; Rüffer M
Int J Pharm; 2003 Jun; 259(1-2):93-101. PubMed ID: 12787639
[TBL] [Abstract][Full Text] [Related]
16. Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir.
Fresta M; Fontana G; Bucolo C; Cavallaro G; Giammona G; Puglisi G
J Pharm Sci; 2001 Mar; 90(3):288-97. PubMed ID: 11170022
[TBL] [Abstract][Full Text] [Related]
17. Combined hydroxypropyl-beta-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir.
Boudad H; Legrand P; Lebas G; Cheron M; Duchêne D; Ponchel G
Int J Pharm; 2001 May; 218(1-2):113-24. PubMed ID: 11337155
[TBL] [Abstract][Full Text] [Related]
18. Ftorafur loading and controlled release from poly(ethyl-2-cyanoacrylate) and poly(butylcyanoacrylate) nanospheres.
Arias JL; Gallardo V; Ruiz MA; Delgado AV
Int J Pharm; 2007 Jun; 337(1-2):282-90. PubMed ID: 17223292
[TBL] [Abstract][Full Text] [Related]
19. Body distribution and in situ evading of phagocytic uptake by macrophages of long-circulating poly (ethylene glycol) cyanoacrylate-co-n-hexadecyl cyanoacrylate nanoparticles.
Huang M; Wu W; Qian J; Wan DJ; Wei XL; Zhu JH
Acta Pharmacol Sin; 2005 Dec; 26(12):1512-8. PubMed ID: 16297352
[TBL] [Abstract][Full Text] [Related]
20. Colloidal dispersions of monodisperse magnetite nanoparticles modified with poly(ethylene glycol).
Barrera C; Herrera AP; Rinaldi C
J Colloid Interface Sci; 2009 Jan; 329(1):107-13. PubMed ID: 18930466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
